Literature DB >> 1686974

The leakage of fatty acid binding protein from cultured myocardial cells during hypoxia.

H Takahashi1, H Kawaguchi, K Iizuka, H Yasuda.   

Abstract

Fatty-acid binding protein (FABP) is thought to play an important role as a carrier protein of fatty acids in cells. It may leak from damaged cells, because its molecular weight is low (mol wt 14000) and it accounts for several percent of soluble protein. In this experiment we attempted to use FABP as a marker of cell injury under hypoxia in cultured myocytes. Newborn-rat myocytes were incubated under hypoxic treatment for 6 hours, and then the releases of FABP and CPK were measured. The cell-death ratio during hypoxygenation increased from 4 hours and rose to 80% at 6 hours, but it was only 8% under aerobic conditions. FABP in medium was detected at 1 hour, and rapidly increased and reached a plateau at 4 hours. On the other hand, CPK in medium was negligible during the 3 hours, then slightly increased. Ca antagonists and a beta 1-adrenergic blocking agent inhibited the release of FABP and prevented cell death. But the alpha 1-adrenergic blocking agent had little effect on preventing FABP leakage and cell death. These results show that FABP is of use as a marker of myocardial cell injury and revealed that the Ca antagonist and beta 1-adrenergic blocking agent are useful drugs for the protection of myocardial cell injury in hypoxia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686974     DOI: 10.1007/bf00143530

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  28 in total

1.  The isolation of a cardiac active principle from mammalian tissue.

Authors:  S HAJDU; H WEISS; E TITUS
Journal:  J Pharmacol Exp Ther       Date:  1957-05       Impact factor: 4.030

2.  A low-molecular-weight protein from rat liver that resembles ligandin in its binding properties.

Authors:  B Ketterer; E Tipping; J F Hackney; D Beale
Journal:  Biochem J       Date:  1976-06-01       Impact factor: 3.857

Review 3.  Metabolism of the heart in health and disease. 3.

Authors:  L H Opie
Journal:  Am Heart J       Date:  1969-03       Impact factor: 4.749

4.  The binding of fatty acids to cytoplasmic proteins: binding to Z protein in liver and other tissues of the rat.

Authors:  S Mishkin; L Stein; Z Gatmaitan; I M Arias
Journal:  Biochem Biophys Res Commun       Date:  1972-06-09       Impact factor: 3.575

5.  Intracellular calcium concentration during hypoxia and metabolic inhibition in mammalian ventricular muscle.

Authors:  D G Allen; C H Orchard
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

6.  The effects of verapamil, quiescence, and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium.

Authors:  P D Bourdillon; P A Poole-Wilson
Journal:  Circ Res       Date:  1982-03       Impact factor: 17.367

7.  Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium.

Authors:  B E Sobel; P B Corr; A K Robison; R A Goldstein; F X Witkowski; M S Klein
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  Prostacyclin biosynthesis and phospholipase activity in hypoxic rat myocardium.

Authors:  H Kawaguchi; H Yasuda
Journal:  Circ Res       Date:  1988-06       Impact factor: 17.367

9.  Effect of various plasminogen activators on prostacyclin synthesis in cultured vascular cells.

Authors:  H Kawaguchi; H Yasuda
Journal:  Circ Res       Date:  1988-12       Impact factor: 17.367

10.  Fatty acid binding protein of cardiac muscle in spontaneously hypertensive rats: effect of hypertrophy and its regression.

Authors:  S Fujii; H Kawaguchi; H Okamoto; H Saito; H Togashi; H Yasuda
Journal:  J Mol Cell Cardiol       Date:  1988-09       Impact factor: 5.000

View more
  1 in total

Review 1.  Significance of cytoplasmic fatty acid-binding protein for the ischemic heart.

Authors:  J F Glatz; M M Vork; G J van der Vusse
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.